Form 8-K - Current report:
SEC Accession No. 0001213900-20-017179
Filing Date
2020-07-10
Accepted
2020-07-10 13:30:12
Documents
1
Period of Report
2020-07-10
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea124061-8k_citius.htm 8-K 16848
  Complete submission text file 0001213900-20-017179.txt   18170
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 201022705
SIC: 2834 Pharmaceutical Preparations